Reuters logo
BRIEF-IntelGenx submits Montelukast VersaFilm(tm) clinical trial application with Health Canada
November 9, 2017 / 10:01 PM / 12 days ago

BRIEF-IntelGenx submits Montelukast VersaFilm(tm) clinical trial application with Health Canada

Nov 9 (Reuters) - IntelGenx Technologies Corp

* IntelGenx submits Montelukast VersaFilm(tm) clinical trial application with Health Canada

* IntelGenx - ‍submitted CTA to Health Canada for approval to initiate its Phase 2a POC study with Montelukast in mild to moderate alzheimer’s disease​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below